Related references
Note: Only part of the references are listed.Favorable Prognosis in Patients With T1a/T1bN0 Triple-Negative Breast Cancers Treated With Multimodality Therapy
Alice Y. Ho et al.
CANCER (2012)
Dissecting the Heterogeneity of Triple-Negative Breast Cancer
Otto Metzger-Filho et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
Farrell C. Adkins et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
Soley Bayraktar et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
Nils D. Arvold et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer
Leonel F. Hernandez-Aya et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
Bassam S. Abdulkarim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
Joyce O'Shaughnessy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
Edith A. Perez et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcome After Breast Conservation Treatment with Radiation for Women with Triple-Negative Early-Stage Invasive Breast Carcinoma
Lawrence J. Solin et al.
CLINICAL BREAST CANCER (2009)
Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel
Ewan K. A. Millar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group
Marianne Kyndi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy
TA Buchholz et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
